{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["77(4)"],"submitter":["Andiappan AK"],"funding":["National Center for Advancing Translational Sciences","National Institute of Allergy and Infectious Diseases","NCATS NIH HHS","NIAID NIH HHS","Agency for Science, Technology and Research","National Medical Research Council"],"journal":["Allergy"],"pagination":["1297-1299"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8960346"],"repository":["biostudies-literature"],"pubmed_title":["Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease."],"pmcid":["PMC8960346"],"funding_grant_id":["202D800012","R21 AI146804","KL2 TR001071","OFYIRG17nov065","5KL2TR001071","R21AI146804"],"pubmed_authors":["Duan K","Jerschow E","Ren Z","Sehanobish E","Akbar N","Lum J","Chan XY","Gibber M","Rotzschke O","Asad M","Ang N","Chua C","Lee B","Howland S","Abuzeid WM","Gersten A","Porcelli SA","Andiappan AK"],"additional_accession":[]},"is_claimable":false,"name":"Neutrophilic inflammation and epithelial barrier disruption in nasal polyps characterize non-steroidal anti-inflammatory drug exacerbated respiratory disease.","description":null,"dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-22T11:52:00.416Z","creation":"2025-04-06T00:05:36.743Z"},"accession":"S-EPMC8960346","cross_references":{"pubmed":["34921681"],"doi":["10.1111/all.15198"]}}